Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 29, 2017

DrugPatentWatch Database Preview

Hydrocodone bitartrate; pseudoephedrine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for hydrocodone bitartrate; pseudoephedrine hydrochloride and what is the scope of freedom to operate?

Hydrocodone bitartrate; pseudoephedrine hydrochloride
is the generic ingredient in two branded drugs marketed by Tris Pharma Inc, Cypress Pharm, Mayne Pharma Inc, and Paddock Llc, and is included in four NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are twenty-two drug master file entries for hydrocodone bitartrate; pseudoephedrine hydrochloride. One supplier is listed for this compound.

Summary for Generic Name: hydrocodone bitartrate; pseudoephedrine hydrochloride

Drug Master File Entries: see list22
Suppliers / Packagers: see list1
Clinical Trials: see list1,061
Drug Prices:see low prices
DailyMed Link:hydrocodone bitartrate; pseudoephedrine hydrochloride at DailyMed

Pharmacology for Ingredient: hydrocodone bitartrate; pseudoephedrine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mayne Pharma Inc
hydrocodone bitartrate; pseudoephedrine hydrochloride
SOLUTION;ORAL205658-001Nov 17, 2015AARXNoNo► Subscribe► Subscribe
Cypress Pharm
hydrocodone bitartrate; pseudoephedrine hydrochloride
SOLUTION;ORAL022442-001Jun 8, 2011AARXYesYes► Subscribe► Subscribe
Paddock Llc
hydrocodone bitartrate; pseudoephedrine hydrochloride
SOLUTION;ORAL204658-001Apr 29, 2014AARXNoNo► Subscribe► Subscribe
Tris Pharma Inc
hydrocodone bitartrate; pseudoephedrine hydrochloride
SOLUTION;ORAL203839-001Oct 28, 2014AARXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Formulary management

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus